Insurance does cover TMS for OCD in a growing number of cases, but coverage is uneven: several commercial insurers now pay for deep transcranial magnetic stimulation when you meet strict clinical criteria, others still classify it as experimental and deny every claim, Medicare coverage depends on which regional contractor administers your area, and most Medicaid programs exclude it. Whether your treatment is paid for comes down to your specific carrier, your plan, and how well your medication and therapy history is documented.
Which Commercial Insurers Pay for It
Coverage differs sharply by carrier. Device manufacturer NeuroStar reports that new payers are regularly adding OCD to their covered conditions,1NeuroStar. Insurance so a policy that excluded TMS a year ago may cover it now.
Insurers that currently cover deep TMS for OCD, each with their own prerequisites:
- Cigna covers deep TMS for OCD under its medical policy effective March 2026. You must be 18 or older, have failed at least two medication trials at adequate doses for eight weeks each, and have tried evidence-based psychotherapy without significant improvement. The initial course covers 30 to 36 sessions, and repeat treatment is allowed if you achieved more than a 30% improvement on the Yale-Brown Obsessive Compulsive Scale and held it for at least two months.2Cigna. Coverage Position Criteria: Transcranial Magnetic Stimulation
- Blue Cross Blue Shield of Michigan and Blue Care Network treat TMS for OCD as “established” under their joint policy effective May 2026. Coverage requires refractory OCD, defined as two failed medication trials plus psychotherapy and one failed augmentation attempt. The approved regimen is 36 sessions over roughly eight weeks, including a taper.3Blue Cross Blue Shield of Michigan. Joint Medical Policy: Transcranial Magnetic Stimulation
- Centene (including Ambetter and its subsidiaries) covers deep TMS for OCD under clinical policy CP.BH.201, with the strictest requirements of any carrier reviewed: four failed medication trials from at least two drug classes combined with CBT or exposure and response prevention for at least 12 weeks, showing less than 25% improvement on the Y-BOCS. Up to 36 sessions are authorized.4Centene. Deep Transcranial Magnetic Stimulation for OCD Clinical Policy
- Providence Health Plan covers TMS for OCD as of January 2026. You need moderate or greater severity on a standardized scale, must be 18 or older, and must have failed or been unable to tolerate at least three medications including clomipramine and an SSRI. A standard course is up to 30 sessions plus six tapering sessions.5Providence Health Plan. Medical Policy: Transcranial Magnetic Stimulation
Insurers that still exclude or do not cover TMS for OCD:
- Aetna classifies TMS for OCD as “experimental, investigational, or unproven” in its clinical policy bulletin and does not cover it.6Aetna. Clinical Policy Bulletin: Transcranial Magnetic Stimulation
- UnitedHealthcare’s medical policy for physical conditions does not address OCD and refers behavioral health decisions to Optum’s separate clinical policy, so coverage depends on that policy and your specific plan.7UnitedHealthcare. Transcranial Magnetic Stimulation Medical Policy
- Tricare covers TMS only for major depressive disorder. OCD is not listed as an approved indication.8TRICARE. Transcranial Magnetic Stimulation
- Humana’s Louisiana Medicaid policy explicitly excludes TMS for any diagnosis other than major depression.9Humana. Transcranial Magnetic Stimulation Policy
- Kaiser Permanente Washington’s published review criteria address depression but say nothing about OCD; non-depression requests are sent to a medical director for individual review.10Kaiser Permanente. Clinical Review Criteria: rTMS
Plan-level variations can override a carrier’s general policy, so the only reliable way to confirm your coverage is to call the number on your insurance card or have the treating provider run a benefits verification before you start.
Medicare and Medicaid
Medicare coverage runs through regional Medicare Administrative Contractors, and their positions on OCD differ by region. Novitas Solutions, which covers a large part of the country, reviewed a request to expand TMS coverage to OCD in 2021 and concluded there was “insufficient evidence” to support it. Under its Local Coverage Determination L34998, TMS for OCD remains non-covered, and reviews in 2022, 2023, and 2024 upheld that position.11Centers for Medicare & Medicaid Services. LCD: Repetitive Transcranial Magnetic Stimulation (L34998)
Palmetto GBA, which covers the southeastern United States and several other jurisdictions, updated its Local Coverage Determination L34869 effective January 2025 to include OCD. Under that policy, TMS for OCD is covered when it is prescribed and administered by a licensed physician experienced in TMS, you have a DSM-5 OCD diagnosis, and you have failed two medication trials and at least eight weeks of evidence-based psychotherapy. A minimum of 29 sessions over six weeks is considered reasonable, with extensions permitted based on clinical response.12Centers for Medicare & Medicaid Services. LCD: Repetitive Transcranial Magnetic Stimulation (L34869)
Medicaid coverage is thin. New York Medicaid, through Healthfirst plans, does not cover TMS for OCD.13Healthfirst. Update on NYS Medicaid Coverage for Therapeutic Transcranial Magnetic Stimulation State Medicaid programs and their managed care organizations set their own rules, so check with your specific plan.
What You Have to Prove to Get Approved
Even where TMS for OCD is covered, approval is never automatic. Every policy reviewed requires prior authorization and clinical documentation showing medical necessity. Specifics vary, but the recurring requirements are:
- A confirmed OCD diagnosis per the DSM, with severity documented on a standardized scale such as the Y-BOCS.
- Failed medication trials. Most insurers require at least two at adequate doses and duration; Centene requires four. Medications typically include SSRIs, SNRIs, and clomipramine. A failed trial means at least six to eight weeks at a therapeutic dose without significant improvement, or intolerable side effects.2Cigna. Coverage Position Criteria: Transcranial Magnetic Stimulation
- An adequate trial of evidence-based psychotherapy, particularly exposure and response prevention, without meaningful improvement. Moda Health, for example, defines an inadequate response as less than a 30% reduction in symptoms.14Moda Health. Medical Necessity Criteria: Transcranial Magnetic Stimulation
- Detailed clinical records: psychiatric evaluations, medication histories with drug names, doses, durations, and outcomes, psychotherapy records, and baseline symptom scores.
- Use of a device with FDA clearance specifically for OCD treatment.4Centene. Deep Transcranial Magnetic Stimulation for OCD Clinical Policy
- Screening for contraindications. Patients with metallic implants near the head, active seizure disorders, active substance use disorders, or pregnancy are typically excluded.
Insurers that cover OCD consistently refuse to pay for maintenance TMS sessions, considering them not medically necessary.2Cigna. Coverage Position Criteria: Transcranial Magnetic Stimulation Accelerated protocols and experimental stimulation methods are also routinely excluded.
Why Deep TMS vs. Standard rTMS Matters for Coverage
The FDA has cleared specific deep TMS devices and protocols for OCD, including the BrainsWay H7 coil (the first device cleared, in 2018),15BrainsWay. BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder the MagVenture cool DB80 coil, and the Neuro-MS/D CloudTMS system. These use high-frequency stimulation at 20 Hz targeting the dorsomedial prefrontal cortex or anterior cingulate cortex, paired with symptom provocation before each session.16International OCD Foundation. TMS
Standard rTMS and theta burst stimulation are used off-label for OCD, meaning they do not carry FDA clearance for that condition. Insurers that cover TMS for OCD generally require an FDA-cleared device, which in practice means deep TMS. If you receive a standard rTMS protocol for OCD, you are more likely to pay for the entire course yourself.
What It Costs Without Coverage
Paying entirely out of pocket, a full course of TMS typically runs $6,000 to $15,000, with individual sessions costing $300 to $500.17Southern Live Oak Wellness. TMS Therapy Cost Without Insurance The International OCD Foundation estimates costs of at least $15,000 for patients without coverage.16International OCD Foundation. TMS Even insured patients remain responsible for copays, coinsurance, and deductibles.
If You’re Denied
Denials are common, especially from insurers that still call TMS for OCD experimental. You have the right to appeal, and advocacy organizations report that many appeals succeed.
- Read the denial letter and identify the specific reason given. Common ones are “not medically necessary,” “investigational or experimental,” missing prior authorization, or incomplete documentation.
- File an internal appeal in writing with supporting documentation. Ask your psychiatrist to write a detailed medical necessity letter that lays out your history of failed treatments.
- Request a peer-to-peer review, where your treating physician speaks directly with the insurer’s medical reviewer. This can resolve denials based on clinical misunderstanding.
- If the internal appeal fails, file an external appeal for independent review by a neutral third party.18National Alliance on Mental Illness. What to Do If You’re Denied Care by Your Insurance
- Invoke mental health parity. Under the federal Mental Health Parity and Addiction Equity Act, insurers cannot impose more restrictive limitations on mental health treatments than on comparable medical treatments. If your plan covers TMS for depression but denies it for OCD despite similar evidence, that distinction could constitute a parity violation.19Depression and Bipolar Support Alliance. Do You Know How to Appeal a Mental Health Insurance Claim Denial
- Contact regulators. File a complaint with your state insurance commission. For self-insured employer plans, the U.S. Department of Labor handles enforcement at 1-866-444-3272.
Help Paying for Treatment
Several resources exist for patients without coverage or facing high out-of-pocket costs:
- NeuroStar Reimbursement Support offers case managers who help patients and providers work through insurance questions. Reach them at 877-600-7555 (option 6).1NeuroStar. Insurance
- The BrainsWay Reimbursement Center provides benefits verification, prior authorization guidance, and appeals support for providers at 844-386-7001.20BrainsWay. Insurance
- The FACTMS Patient Assistance Fund, run by the Foundation for the Advancement of Clinical TMS, offers grants of up to $500 per patient to cover ancillary costs like transportation and lodging. Household income must be at or below 150% of the federal poverty level, and the grant is administered through your treating clinic.21FACTMS. Patient Assistance Fund
- Some TMS clinics offer sliding-scale fees, interest-free payment plans of up to 12 months, or hybrid discount-and-payment arrangements based on financial need.
- HSA and FSA funds can be used to pay for TMS.
- A single case agreement, in which the provider negotiates directly with your insurer for out-of-network coverage on a one-time basis, is worth asking about when standard coverage is unavailable.22BrainsWay. Is Deep TMS Covered by Insurers